CIAM
TXG icon

Caitong International Asset Management’s 10x Genomics TXG Stock Holding History

Caitong International Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Buy
+7,996
New +$210K 0.04% 330
2026
Q1 		– Sell
-883
Closed -$14.4K – 3053
2025
Q4 		$14.4K Sell
883
-483
-35% -$7.3K ﹤0.01% 1068
2025
Q3 		$16K Buy
1,366
+1,026
+302% +$13.4K 0.01% 824
2025
Q2 		$3.94K Buy
340
+335
+6,700% +$3.05K ﹤0.01% 1119
2025
Q1 		$44 Sell
5
-184
-97% -$2.32K ﹤0.01% 2044
2024
Q4 		$2.71K Buy
+189
New +$2.98K ﹤0.01% 1131

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caitong International Asset Management's TXG Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in 10x Genomics (TXG) in Q2 2026: 7,996 shares worth $307K. The stake represents 0.04% of the portfolio and ranks #330 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in TXG as recently as Q4 2025.

Caitong International Asset Management first reported a position in TXG in Q4 2024 and has held it in 6 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Caitong International Asset Management held 7,996 shares of 10x Genomics worth $307K as of Q2 2026.
  • 10x Genomics was a new Caitong International Asset Management position in Q2 2026.
  • 10x Genomics made up 0.04% of Caitong International Asset Management's portfolio in Q2 2026, its #330 holding.
  • Caitong International Asset Management first reported a position in 10x Genomics in Q4 2024 and has held it in 6 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.